AKT1 and ischemic stroke: Interestingly, we found that EA can also inhibit neuronal autophagy and apoptosis via the PI3K/Akt signaling pathway following IS, and it is a safe and effective therapy for ischemic stroke in both clinical and laboratory settings [41].